scispace - formally typeset
Open AccessBook ChapterDOI

Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology.

Jane Kovalevich, +1 more
- 01 Jan 2013 - 
- Vol. 1078, pp 9-21
Reads0
Chats0
TLDR
The popular SH-SY5Y neuroblastoma cell line and its use in in vitro systems is described and Retinoic acid is the most commonly used means for differentiation and will be addressed in detail.
Abstract
The use of primary mammalian neurons derived from embryonic central nervous system tissue is limited by the fact that once terminally differentiated into mature neurons, the cells can no longer be propagated. Transformed neuronal-like cell lines can be used in vitro to overcome this limitation. However, several caveats exist when utilizing cells derived from malignant tumors. In this context, the popular SH-SY5Y neuroblastoma cell line and its use in in vitro systems is described. Originally derived from a metastatic bone tumor biopsy, SH-SY5Y (ATCC® CRL-2266™) cells are a subline of the parental line SK-N-SH (ATCC® HTB-11™). SK-N-SH were subcloned three times; first to SH-SY, then to SH-SY5, and finally to SH-SY5Y. SH-SY5Y were deposited to the ATCC® in 1970 by June L. Biedler. Three important characteristics of SH-SY5Y cells should be considered when using these cells in in vitro studies. First, cultures include both adherent and floating cells, both types of which are viable. Few studies address the biological significance of the adherent versus floating phenotypes, but most reported studies utilize adherent populations and discard the floating cells during media changes. Second, early studies by Biedler's group indicated that the parental differentiated SK-N-SH cells contained two morphologically distinct phenotypes: neuroblast-like cells and epithelial-like cells (Ross et al., J Natl Cancer Inst 71(4):741-747, 1983). These two phenotypes may correspond to the "N" and "S" types described in later studies in SH-SY5Y by Encinas et al. (J Neurochem 75(3):991-1003, 2000). Cells with neuroblast-like morphology are positive for tyrosine hydroxylase (TH) and dopamine-β-hydroxylase characteristic of catecholaminergic neurons, whereas the epithelial-like counterpart cells lacked these enzymatic activities (Ross et al., J Natl Cancer Inst 71(4):741-747, 1983). Third, SH-SY5Y cells can be differentiated to a more mature neuron-like phenotype that is characterized by neuronal markers. There are several methods to differentiate SH-SY5Y cells and are mentioned below. Retinoic acid is the most commonly used means for differentiation and will be addressed in detail.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

The SH-SY5Y cell line in Parkinson's disease research: a systematic review

TL;DR: An overview of the cell source, culture conditions, differentiation protocols, methods/approaches used to mimic PD and the preclinical validation of the SH-SY5Y findings by employing alternative cellular and animal models is described.
Journal ArticleDOI

Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line.

TL;DR: An easy-to-follow, reproducible method to obtain homogenous and viable human neuronal cultures, by differentiating the chromosomally stable human neuroblastoma cell line, SH-SY5Y, which provides researchers with a more accurate translational model of human infection and disease.
Journal ArticleDOI

The Potential Use of Plant Natural Products and Plant Extracts with Antioxidant Properties for the Prevention/Treatment of Neurodegenerative Diseases: In Vitro, In Vivo and Clinical Trials

TL;DR: This review will cover several in vitro and in vivo research studies, as well as clinical trials, and highlight the potential of natural antioxidants in the treatment of patients with neurological disorders.
Journal ArticleDOI

Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity

TL;DR: The involvement of Cdk5 in modulation of brain inflammatory response induced by Aβ is clearly shown and may indicate this kinase as a novel target for pharmacological intervention in AD.
References
More filters
Journal ArticleDOI

Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons

TL;DR: Activation of PKA may be a component of the mechanism that generates L-LTP, and analogs of cAMP induced a potentiation that blocked naturally induced L- LTP, which was blocked by inhibitors of protein synthesis.
Journal Article

Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones.

TL;DR: Continuously cultured human neuroblastoma cell lines SK-N-SH, SK- n-BE, and SK-n-MC, as well as other cell lines used in previous studies, show good tolerability and high cell reprograming ability.
Journal ArticleDOI

Sequential Treatment of SH‐SY5Y Cells with Retinoic Acid and Brain‐Derived Neurotrophic Factor Gives Rise to Fully Differentiated, Neurotrophic Factor‐Dependent, Human Neuron‐Like Cells

TL;DR: This model may be useful to perform large‐scale biochemical and molecular studies due to its susceptibility to genetic manipulation and the availability of an unlimited amount of cells.
Journal ArticleDOI

Coordinate morphological and biochemical interconversion of human neuroblastoma cells.

TL;DR: Findings indicate a coordinate morphological and biochemical interconversion of neuroblastoma SK-N-SH cells and reveal a plasticity in phenotypic expression in malignant neuronal cells.
Journal ArticleDOI

SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.

TL;DR: Evaluating the human neuroblastoma SH-SY5Y cell line as an in vitro model of dopaminergic (DAergic) neurons for Parkinson's disease (PD) research and the effect of differentiation on this cell model found some differentiating agents afford SH- SY5Y cells with more potential for studying neurotoxicity and neuroprotection and are thus more relevant to experimental PD research.
Related Papers (5)
Trending Questions (1)
What is the best time of maturation of SH-SY5Y cells to neuron?

The best time of maturation for SH-SY5Y cells to neuron is a minimum of 3-5 days in the presence of ATRA-containing neurobasal medium.